Status:
COMPLETED
Influence of Risk Factors on ISR and Nonintervened Lesions
Lead Sponsor:
RenJi Hospital
Conditions:
Coronary Artery Disease
Multi Vessel Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
This study enrolled patients who used to received PCI therapy with nonintervened coronary lesions. Baseline characteristics and laboratory testing were collected to find out the risk factor difference...
Eligibility Criteria
Inclusion
- (1) PCI therapy with drug-coated stents was performed in the past, and nonintervened coronary lesion remained except in the target vessel.
- (2) CAG was performed again due to re-examination, recurrent angina symptoms, positive treadmill exercise test or coronary CTA showing moderate to severe vessel diameter stenosis.
- (3) Long-term regular oral administration of statins and lipid monitoring were conducted after PCI.
Exclusion
- Patients with a history of CABG, renal replacement therapy, autoimmune disease, and malignancy
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT06039059
Start Date
January 1 2020
End Date
March 31 2023
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, China, 200127